Clinical trial Recruiting at 1 site Interventional Ages 35 to 70

Latissimus dorsi release added to scapular PNF for adhesive capsulitis

Official title: Effect of Adding Latissimus Dorsi Myofascial Release to Scapular Proprioceptive Neuromuscular Facilitation on Pain, Disability, and Range of Motion in Adhesive Capsulitis: A Randomized Controlled Trial

Run by Ibadat International University, Islamabad · NCT07588087 · Data updated 2026-11-12

This trial tests whether adding latissimus dorsi myofascial release to scapular PNF helps reduce pain and improve motion and function in people with stage II frozen shoulder.

More Adhesive Capsulitis trials

Quick facts

Study typeInterventional
Ages35 Years to 70 Years
SexAll
Enrollment58 (estimated)
SponsorIbadat International University, Islamabad
Academic / other
Locations1 site (Islamabad, Punjab Province)
StatusRecruiting
StartedApril 5, 2026
Main results expectedJune 6, 2026
Study endsJune 8, 2026
Registry record updatedMay 14, 2026
Trial IDNCT07588087 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 35–70 with stage II adhesive capsulitis and a pain score of at least 4/10 during movement.

Probably not a fit

Patients with secondary adhesive capsulitis, bilateral involvement, recent corticosteroid injections, or other exclusion criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized study, participants with stage II adhesive capsulitis are assigned to receive either scapular PNF hold-relax therapy alone or PNF plus latissimus dorsi myofascial release over 6 weeks (3 sessions per week). Outcomes include pain (NPRS), shoulder range of motion, latissimus dorsi tightness, and function (SPADI), analyzed with SPSS v26. Both groups receive the same duration and frequency of treatment. The goal is to determine if adding the myofascial release provides additional benefits beyond scapular PNF alone.

Why it matters

Potential benefit: If successful, patients may experience greater pain relief, better shoulder movement, and improved daily function.

How similar studies have gone: Prior work has shown benefits from targeted manual therapies and PNF in frozen shoulder, but combining latissimus dorsi release with scapular PNF is less established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\. Age between 35 and 70 years.
* Both male and female participants.
* Stiffening (Stage II) phase of frozen shoulder.
* Pain intensity ≥ 4/10 on NPRS during shoulder movement.
* Unilateral shoulder involvement.
* Presence of capsular pattern:ER \> ABD \> IR limitation
* Apley's Scratch Test
* Limited both ROMs
* Symptom duration between 3 and 9 months.(Di Mascio et al., 2024)

Exclusion Criteria:

* Secondary adhesive capsulitis due to trauma or surgery
* History of shoulder fracture or dislocation.
* Bilateral frozen shoulder.
* Active systemic inflammatory or neurological disease
* Recent intra-articular corticosteroid injection (within last 3 months)
* Current anticoagulation therapy or bleeding disorders.
* Pregnant females.

Where it's running

  • • Ibadat international hospital • Shaafi international hospital • South East hospital • Fauji Foundation hospital
    Islamabad, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.